Human soluble tumor necrosis factor-related apoptosis inducing ligand (TNFSF10) ELISA Kit for soluble tumor necrosis factor-related apoptosis inducing ligand in human research samples.
Know who made it. See the evidence. Buy through one marketplace.
Human soluble tumor necrosis factor-related apoptosis inducing ligand (TNFSF10) ELISA Kit is a research-use ELISA kit from CUSABIO for measuring soluble tumor necrosis factor-related apoptosis inducing ligand in Serum, Plasma, plasma (EDTA), Tissue homogenates samples from Homo sapiens (Human). Use the listed assay range, sample guidance and protocol documents to assess suitability for the intended study.
For research use only. Not for diagnostic procedures.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Sample compatibility evidence using the same validation key.
| Sample type | serum | plasma | plasma (EDTA) | tissue homogenates |
|---|---|---|---|---|
| serum | ||||
| plasma | ||||
| plasma (EDTA) | ||||
| tissue homogenates |
This product is manufactured by CUSABIO and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
